Patents Assigned to National Biological Corporation
  • Publication number: 20130245724
    Abstract: A phototherapeutic device comprises a system for facilitating phototherapeutic treatment. The system comprises an input device configured to receive input from a user. The system further comprises a display device configured to communicate information to the user. The system further comprises a controller. The controller is configured to receive user identification data from the input device. The controller is further configured to retrieve treatment history based on the user identification data. The controller is further configured to retrieve a treatment protocol based on the user identification data. The controller is further configured to generate a suggested treatment based on the retrieved treatment history and the retrieved treatment protocol. The controller is further configured to communicate the suggested treatment to the display device.
    Type: Application
    Filed: March 13, 2013
    Publication date: September 19, 2013
    Applicant: National Biological Corporation
    Inventor: Michael Kaufman
  • Patent number: 8486124
    Abstract: A phototherapy treatment dispensing device provides therapeutic light emissions treatments. The device provides additional means for controlling a patient's exposure to those treatments through a controlled protocol timer. The controlled protocol timer can provide for incremental exposure increases; monitors patient compliance with a treatment regimen; and reminds the patient when a treatment will soon be overdue.
    Type: Grant
    Filed: November 15, 2007
    Date of Patent: July 16, 2013
    Assignee: National Biological Corporation
    Inventors: Steven Hendrix, Kenneth Oif, Michael Kaufman
  • Publication number: 20080125834
    Abstract: A phototherapy treatment dispensing device provides therapeutic light emissions treatments. The device provides additional means for controlling a patient's exposure to those treatments through a controlled protocol timer. The controlled protocol timer can provide for incremental exposure increases; monitors patient compliance with a treatment regimen; and reminds the patient when a treatment will soon be overdue.
    Type: Application
    Filed: November 15, 2007
    Publication date: May 29, 2008
    Applicant: NATIONAL BIOLOGICAL CORPORATION
    Inventors: Steven Hendrix, Kenneth Oif, Michael Kaufman
  • Patent number: D249552
    Type: Grant
    Filed: March 1, 1976
    Date of Patent: September 19, 1978
    Assignee: National Biological Corporation
    Inventor: Jack H. Schwartz